Drug Shortage Report for RABAVERT
Report ID | 96846 |
Drug Identification Number | 02267667 |
Brand name | RABAVERT |
Common or Proper name | Rabies Vaccine |
Company Name | BAVARIAN NORDIC AS |
Market Status | MARKETED |
Active Ingredient(s) | RABIES VACCINE INACTIVATED |
Strength(s) | 2.5UNIT |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging size | 1's |
ATC code | J07BG |
ATC description | VIRAL VACCINES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-10-17 |
Estimated end date | 2020-01-02 |
Actual end date | 2020-01-02 |
Shortage status | Resolved |
Updated date | 2020-01-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | PHILIP HEYMANS ALLE 3 HELLERUP, -- DENMARK 2900 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-01-03 | English | Compare |
v6 | 2020-01-02 | French | Compare |
v5 | 2020-01-02 | English | Compare |
v4 | 2019-12-13 | French | Compare |
v3 | 2019-12-13 | English | Compare |
v2 | 2019-10-18 | French | Compare |
v1 | 2019-10-18 | English | Compare |
Showing 1 to 7 of 7